Psychopharmacology and Psychiatry Updates COVID Brain Fog: Repurposing Famotidine
Jan 16, 2025
Scott Beach, an expert in psychopharmacology, shares groundbreaking research on famotidine, a common heartburn medication, and its potential to treat post-COVID brain fog. The discussion highlights the cognitive challenges faced by recovering patients and how this unlikely candidate could alleviate mental haziness. Beach dives into the mechanisms behind famotidine’s effects and presents compelling evidence from clinical assessments. The conversation underscores the urgent need for effective treatments for those grappling with lingering cognitive impairment.
AI Snips
Chapters
Transcript
Episode notes
Physician's Brain Fog Experience
- Sarah, a 45-year-old physician, experiences brain fog after mild COVID.
- She struggles with tasks like patient notes due to diminished mental clarity.
Famotidine's Unexpected Benefits
- Famotidine, a common heartburn drug, has shown potential in improving post-COVID brain fog.
- It may reduce inflammation and has possible antiviral effects against SARS-CoV.
Cognitive Improvement with Famotidine
- Famotidine improved cognitive scores at 6 and 12 weeks in post-COVID patients with brain fog.
- It also showed some improvement in depression and anxiety scores.